genomics

My newest investment: Genalyte — Augmenting Claremont Creek Ventures’ Digital Healthcare Tools Portfolio

By Brad Webb / April 2, 2012 / 0 Comments

I’m excited that we have recently added a new portfolio company Genalyte to the Claremont Creek digital healthcare family. I’ll be joining the Board, and I am looking forward to working with founder and CEO Cary Gunn and the Genalyte team. Genalyte is a developer and manufacturer of advanced biomarker detection technology strategically located right […]

Read More

Meet our team

Claremont Creek Ventures was founded in 2005 by Nat Goldhaber, John Steuart and Randy Hawks to pursue early stage investing in exceptional technology startups.

Nat_Boldhaber7718 -1200px

NAT GOLDHABER

Nat Goldhaber is a co-founder of Claremont Creek Ventures. 

READ MORE
Brad_Webb8124 1200px crop

BRAD WEBB

Brad is focused on the role of genomics and biomarker data analytics in driving the next generation of diagnostics and drug development.

READ MORE
Randy_Hawks7690 -1200px

RANDY HAWKS

Randy Hawks is a co-founder of Claremont Creek Ventures.

READ MORE

Post Categories

Keywords

energy tech gene disorder testing bionics corporate venture funding power generation Series B carried interest mentoring bioinformatics stem cell market uncertainty DOOH genetic screening solar market conditions awards chromosone screening Personalized Pharmacology private equity early-stage video SVASE exit funding thermoelectric cleantech greentech words-of-wisdom IPO M&A government programs swtching costs startups innovation cloud computing Digital Healthcare angel investor smartgrid renewable energy government policies energy conservation government funding healthcare energy storage targeted customer segments

Archives